Monday, August 20, 2012

EBF 5th Open Symposium - Last Call for Speakers

European Bioanalysis Forum
5th Open Symposium
Old Battles - New Horizons
November 14-16, 2012 • Hesperia Tower Hotel • Barcelona • Spain


Only 3 weeks until the submission deadline for oral presentations and competing posters!

The theme of the 5th Open Symposium is "Old Battles – New Horizons", where we intend to discuss ongoing ambiguities in areas like the tiered approach, micro sampling and tissue analysis as well as new and cutting edge applications in LBA and LC-MS/MS.  We anticipate to bring an exciting program which combines above with regulated bioanalysis themes, including updates from the globe (i.e. GBC and emerging regulations).  The draft program can be found on our website at:

Following up on the recent announcements on an upcoming Crystal City (CC-V) meeting on the (to be released) draft FDA BMV guidance (, the Organizing Committee (OSOC) has decided to adapt the program of the Open Symposium and host a 1-day discussion on Friday Nov. 16th on the draft Guideline in front of this planned CC-V meeting (in continuation of this mail called ‘EBF FDA-BMV guidelines session’). We anticipate to create minimal impact on the original content of our 5th Symposium. The sessions that were originally scheduled for Friday will be included in the program of Nov. 14th and 15th, either by shortening some other sessions or by creating additional breakouts. The OSOC will work out a detailed agenda in the coming weeks.
In the EBF FDA-BMV guidelines session, it is our goal to include speakers who are closely involved in the preparation of the CC-V meeting, provide feedback from speakers around the globe and discuss the EBF consolidated feedback. Breakouts will be arranged for small molecules/chromatography and large molecules/LBA discussions.
We are aware of the current vagueness of the AAPS announcement. Of course, if no draft FDA Guideline is available at the time of the EBF Open Symposium, we will re-adapt the program accordingly, with focus of the Friday remaining on emerging guidelines as originally planned.


Speakers are requested to submit their contribution to, before September 10th  2012, providing title of the presentation, a recent bio (max 150 words) and an abstract (max 350 words). The registration fee is waived for accepted speakers. As the summer breaks are approaching rapidly, do not hesitate to submit your talk soon. And preferably identify the session you plan to contribute to. See also:


The EBF would also like to invite registrations for posters. This year, there will be a different approach to the poster sessions. You can either submit a regular poster (before October 15th 2012) or apply for the ‘Best Poster‘ content (in which case you poster + abstract needs to be submitted before September 10th2012  (see more details on the poster registration form at: All posters, need to be submitted to:
Meeting Organisation
Richard Abbott (Shire), Begona Barroso (Astellas), Magnus Knutsson (Ferring), Steve White (GSK), Peter van Amsterdam (Abbott), Margarete Brudny-Kloeppel (Bayer Healthcare), Arjen Companjen (Crucell), Michaela Golob (Merck-Serono), Silke Luedtke (Boehringer Ingelheim), Philip Timmerman (Janssen R&D),
Sponsor relations, marketing and logistics: Christina Smith, Bavalan Bioconference  SARL
The conference is organised as a non-profit event on behalf of the EBF vzw
The organisation of the conference is independent of all EBF member companies and conference sponsors.

No comments:

Post a Comment